Decreased glucose-6-phosphate dehydrogenase levels in vitiligo patients: Further evidence of oxidative stress

Authors

1 Skin Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

2 WK Transplant Center, Shreveport, LA, USA

3 Student Research Center, Fasa University of Medical Sciences, Fasa, Iran

4 Shiraz Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

1. Laddha NC, Dwivedi M, Mansuri MS, Gani AR, Ansarullah M, Ramachandran AV, et al. Vitiligo: Interplay between oxidative stress and immune system. Exp Dermatol 2013;22:245-50.  Back to cited text no. 1
    
2. Bahmani M, Fallahzadeh MK, Jowkar F, Khalesi M, Bahri-Najafi R, Namazi MR. Can topical phenytoin augment the therapeutic efficacy of PUVA against vitiligo? A double-blind, randomized, bilateral-comparison, placebo-controlled study. J Dermatolog Treat 2011;22:106-8.  Back to cited text no. 2
[PUBMED]    
3. Ho HY, Cheng ML, Chiu DT. Glucose-6-phosphate dehydrogenase-from oxidative stress to cellular functions and degenerative diseases. Redox Rep 2007;12:109-18.  Back to cited text no. 3
[PUBMED]    
4. Arican O, Kurutas EB. Oxidative stress in the blood of patients with active localized vitiligo. Acta Dermatovenerol Alp Panonica Adriat 2008;17:12-6.  Back to cited text no. 4
[PUBMED]    
5. Agrawal D, Shajil EM, Marfatia YS, Begum R. Study on the antioxidant status of vitiligo patients of different age groups in Baroda. Pigment Cell Res 2004;17:289-94.  Back to cited text no. 5
[PUBMED]    
6. Akoglu G, Emre S, Metin A, Akbas A, Yorulmaz A, Isikoglu S, et al. Evaluation of total oxidant and antioxidant status in localized and generalized vitiligo. Clin Exp Dermatol 2013;20 [In Press].  Back to cited text no. 6